A very recent investigation demonstrated a new mechanism by which the oncoprotein c-Myc enables cancer cells to acquire cisplatin resistance by suppressing BIN1, thereby releasing the DNA repair protein poly(ADP-ribose)polymerase (PARP) 1 [5] (Figure 3). Here, BIN1 is linked to cancer.